Advisory on COVID-19 Protocols for Quarantine and Isolation

Amendment to DM No. 2021-0492: Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/Additional Doses to Priority Group A2: Senior Citizens ages 60 years old & above and Priority Group A3…

Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/ Additional Doses to Priority Group A2: Senior Citizen ages 60 years old and above and Priority A3: Adults with Comorbidities

Reiteration of the Interim Operational Guidelines on the Administration of COVID-19 Vaccine Booster Dose to Priority Group A1: Essential Workers in Frontline Health Services (A1.1 to A1.7)

Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities

Amendment of Joint Memorandum Circular of DOH-DTI-DOLE-DILG-DOTr-PSC-GAB entitled “Clarificatory Guidelines on the Mandatory Use of Face Shields Outside of Residence for COVID-19 Mitigation”

Reiteration of Department Circular No. 2021-0323 on price cap for COVID-19 Rapid Antigen Testing

Price Cap for COVID-19 Reverse Transcriptions-Polymerase Reaction (RT-PCR) Testing

Reiteration of functions of Infectious Control Committees in health facilities and modification of staffing patterns and further clarification of the shortening of quarantine for the healthcare workers

Guidelines for the Management and administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine

Procedures on the Procurement and Distribution of COVID-19 Vaccines for Private Entities

Implementing Guidelines for Priority Groups A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines